IP Library Granted Patent US 9,814,513
Granted Patent B2
US 9,814,513 · App. 14/631,927 · Granted Nov 14, 2017

Endovascular plasma treatment device and method of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,814,513
App. No.
14/631,927
Granted
Nov 14, 2017
Kind
B2
Abstract

A device and method for treating a hollow anatomical structure using matter in a plasma state. Device includes a tubular delivery device comprising a tubular body, a hub, and a distal end, wherein the tubular body device having a longitudinal fluid delivery channel and an exit port near the distal end. Device also contains a container having pre-plasma matter being operatively coupled to the hub, at least one energy-emitting element operatively coupled near the distal end of the tubular delivery device. The energy-emitting element is operatively connected to energy source.

Claims (30)

1. An endoluminal treatment method comprising:

accessing an anatomical lumen;

inserting into an anatomical lumen a catheter having at least one energy emitting element near the distal end of the catheter and a catheter lumen;

activating the energy emitting element to create plasma wherein the plasma causes shrinkage of the anatomical lumen by altering a cellular component of a cellular lining of the anatomical lumen to induce non-thermal cell death.

2. The method of claim 1 , wherein plasma is created from pre-plasma matter by activating the energy emitting element.

3. The method of claim 2 , wherein the pre-plasma is in a fluid state.

4. The method of claim 3 , wherein the pre-plasma comprises a saline.

5. The method of claim 1 , wherein the step of inserting includes the energy emitting element comprising an optical fiber.

6. The method of claim 1 , wherein the step of inserting includes the energy emitting element comprising an electrode.

7. The method of claim 6 , wherein the electrode further comprises a radiofrequency electrode.

8. The method of claim 6 , wherein the electrode further comprises an electroporation electrode.

9. The method of claim 6 , wherein the electrode further comprises a microwave antenna.

10. The endoluminal treatment method of claim 1 , wherein the plasma causing shrinkage of the anatomical lumen comprises low-level thermal plasma.

11. An endoluminal treatment method comprising:

accessing a varicose vein;

inserting into a varicose vein a catheter having at least one energy emitting element and a catheter lumen;

activating the at least one energy emitting element to create plasma wherein the plasma causes shrinkage of the varicose vein by altering a cellular component of a cellular lining of the varicose vein to induce non-thermal cell death.

12. The method of claim 11 , wherein plasma is created from pre-plasma matter by activating the energy emitting element.

13. The method of claim 12 , wherein the pre-plasma is in a fluid state.

14. The method of claim 13 , wherein the pre-plasma comprises a saline.

15. The method of claim 11 , wherein the step of inserting includes the energy emitting element comprising an optical fiber.

16. The method of claim 11 , wherein the step of inserting includes the energy emitting element comprising an electrode.

17. The method of claim 16 , wherein the electrode further comprises a radiofrequency electrode.

18. The method of claim 16 , wherein the electrode further comprises an electroporation electrode.

19. The method of claim 16 , wherein the electrode further comprises a microwave antenna.

20. The endoluminal treatment method of claim 11 , wherein the plasma causing shrinkage of the anatomical lumen comprises low-level thermal plasma.

21. An endoluminal treatment device comprising:

an energy generator comprising a device capable of generating an energy field to excite pre-plasma matter sufficiently to convert the matter to plasma, the plasma altering a cellular component of a cellular lining of an anatomical lumen to induce non-thermal cell death;

a delivery catheter; and

a connection between the energy generator and delivery catheter.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2022
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 061363/0446 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Jun 5, 2019
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 049371/0657 →
SECURITY INTEREST Recorded Nov 8, 2016
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 040613/0049 →